Journal issues > Issue Special, February 2023 > Skin cancer session

Skin cancer session

The skin cancer session of the 25th annual meeting of The Belgian Society for Medical Oncology highlighted recent advances in the treatment of patients with melanoma and other skin cancers. Beginning this session, Prof. Dr. Vibeke Kruse (VITAZ – AZ Nikolaas, Sint-Niklaas) discussed adjuvant and neoadjuvant treatments for melanoma. Subsequently, Prof. Dr. Oliver Bechter (University Hospitals Leuven, Leuven) outlined recent findings in metastatic melanoma. Prof. Dr. Jean-Francois Baurain (Cliniques Universitaires St Luc, Brussels) followed up with a ‘survival guide’ for medical oncologists dealing with non-melanoma skin cancer. Dr. Tess van Meerhaeghe (Hôpital Erasme, Cliniques Universitaires de Bruxelles, Brussels) closed the session with an overview of immune checkpoint inhibitors in kidney transplant recipients.

To read the full artice you have the following options:

* (only possible for healthcare professionals with RIZIV/INAMI/MATRICULE working in the field of Oncology/Hemato-oncology in Belgium and Luxembourg with prescription authorisation)

Purchase this article for €3.03

** (for healthcare professionals with prescribing authorisation working outside the field of Oncology/Hemato-oncology in Belgium and Luxembourg as well as those without prescribing authorisation working as healthcare professional in Oncology/Hemato-oncology in Belgium and Luxembourg, plus persons without prescription authorisation working outside Belgium and Luxembourg, plus healthcare professionals with prescribing authorisation outside Belgium and Luxembourg plus non-healthcare professionals from outside or inside Belgium or Luxembourg)

Top